NATIONAL PRIMATE RESEARCH CENTER
Institutional Animal Care & Use Committee
Protocol for the Use of Nonhuman Primates
for Research, Teaching or Demonstration
Protocol #:
TNPRC 18703 Three Rivers Rd, Covington, LA. 70433
(985-871-6636)
IACUC Office 1430 Tulane Ave TB 23 N.O., LA. 70112
(504-988-6868)
Vet Assigned:
Approval Date:
Census Code:
Project #:
Email a copy of this protocol to iacuc@tulane.edu
Date Filed:
Principal Investigator:
Division: select one
Other:
Address/Mailbox:
E-mail:
Position/Title:
Phone:
Co-investigator and/or TNPRC contact:
Position/Title:
Division: select one
Additional Contact Person(s):
Emergency Contact:
Lab Phone:
(required if PI is an outside collaborator)
E-mail:
Phone:
Email:
Phone:
TITLE OF PROTOCOL:
List the title of the grant only if it differs from the protocol title:
FUNDING AGENCY OR SOURCE:
DURATION OF PROJECT:
Project Start Date:
Please include animal use for the duration of the entire study. While protocols are approved for three years the
IACUC needs to review the complete project.
IS THIS PROTOCOL A SUBCONTRACT OR FEE-FOR-SERVICE?
YES (If the PI of the grant is affiliated with an institution other than TNPRC, “yes” should be indicated.) IF YES,
INDICATE PI OF THE GRANT:
NO
INITIAL PROTOCOL –Proceed to Section II. Species
RENEWAL PROTOCOLS – List current protocol number:
Version 2012
Page 1 of 11
and complete Section I.A. and B.
SECTION I. RENEWAL PROTOCOLS ONLY
A. Please enter a brief summary of what has been accomplished thus far so that the continuation efforts described in
this protocol can be better understood. Please include any relevant publications from your study.

B. Please list the animals assigned to the previous protocol that will continue on this protocol. Do not list any
animals released from the project (transferred or dead). If this protocol involves multiple projects you must list the
animals per project.
SPECIES
PROJECT #
NUMBER
USDA
CATEGORY
.
.
.
.
.
.
.
.
.
.
Other:
.
Comment:
SECTION II. SPECIES, NUMBER & CATEGORY OF ANIMAL USE for animals to be assigned to this
project - Do not include animals listed in Section I .B. If this protocol involves multiple projects you must list the
animals per project.
SPECIES
PROJECT #
NUMBER
.
.
.
.
.
.
Comment:
USDA
CATEGORY
.
.
.
.
.
.
*USDA Category: for a complete description please go to http://tulane.edu/asvpr/iacuc/hsc/
SECTION III. USE OF ANIMALS ASSIGNED TO OTHER PROTOCOLS
Approval of a protocol that utilizes animals assigned to other protocols binds the principal investigator into an
agreement to coordinate all animal sampling and procedures with the corresponding principal investigator so that all
procedures follow the guidelines by the governing agencies and the IACUC
PROTOCOL
#
SPECIES
.
.
.
.
Version 2012
# OF
ANIMALS
USDA
CATEGORY
.
.
.
.
Page 2 of 11
PI SIGNATURE- If you are piggybacking
your own protocol, then you must have
the signature of assigned veterinarian for
the parent protocol.
Comment:
If you have chose one of the Breeding colony protocols please review the Policy for Piggybacked Use of Breeding
Colony Nonhuman Primates and complete the checkbox below.
I have read the Policy for Piggybacked Use of Breeding Colony Nonhuman Primates
IMPORTANT
Questions must be answered completely for the protocol to undergo IACUC review.
Do not refer to or attach passages from grants.
SECTION IV. REGULATORY INFORMATION
Please check YES or NO as it applies to the animals requested. If you answer YES to a question, you must provide
an explanation and justification.
1. Is this an endangered or threatened species?
No
Yes - Provide explanation and justification:
2. Is short-term (> 30 minutes; < 12 hours) physical restraint of a conscious animal employed?
No
Yes - Provide explanation and justification:
3.
Is long-term (12 hours or more) physical restraint of a conscious animal employed?
No
Yes - Provide explanation and justification:
4.
Will specialized management procedures be required, e.g. specialized caging equipment, restricted or altered
feeding/watering/sanitization schedules, periods of isolation from other nonhuman primates, or environmental
parameters such as cage size, temperature, lighting or other fall outside the “Guide for the Care and Use of
Laboratory Animals”?
No
Yes - Provide explanation and justification:
5.
Will you perform more than one major survival surgery on any animal? PLEASE NOTE: Major survival
surgery penetrates and exposes a body cavity or produces substantial impairment of physical or physiological
functions (such as laparotomy, thoracotomy, craniotomy, joint replacement or limb amputation).
No
Yes - Provide explanation and justification:
6.
Will animals be housed outside of AAALAC-accredited Tulane facilities for over 12 consecutive hours? If
YES, the proposed site must be inspected and approved by the IACUC prior to use. Please list the location with
justification below.
No
Yes - Provide explanation and justification:
7.
Will pain or distress be experienced where the use of analgesic or anesthetic agents is not allowed because of
experimental protocol? This is Category E and must be scientifically justified with references.
No
Yes - Provide explanation and justification:
8.
Will these procedures be filmed, videotaped or photographed for use outside the institution? If so, you must
obtain approval from the Executive Director of Comparative Medicine. (985-871-6285)
No
Version 2012
Page 3 of 11
Yes - Provide explanation and justification:
SECTION V. PERSONNEL HAZARDS
A. Is there potential exposure of humans to chemical hazards, physical hazards, radioactive agents, or biohazardous
agents during the course of animal experimentation?
No
Yes - please respond to the choices below.
Physical (includes radioactive hazards) Describe:
Chemical
Describe:
Biohazards
Describe:
Does this biohazard require IBC approval?
NO
YES- IBC approval #
Describe:
Does this biohazard require IBC approval?
NO
YES- IBC approval #
Describe:
Does this biohazard require IBC approval?
NO
YES- IBC approval #
Questions regarding IBC approval should be directed to http://tulane.edu/asvpr/biosafety/committee/
SECTION VI. NON-TECHNICAL SUMMARY
Using non technical language that a layperson without scientific knowledge would understand, provide a brief
summary that describes the nature and purpose of this study and its potential value to human or animal health, the
advancement of knowledge or the betterment of society. Do not use scientific terminology, acronyms, or
abbreviations and do not cut and paste passages from your grant application.

SECTION VII. COMPLETE DESCRIPTION OF ANIMAL USE
A. CONCISE DESCRIPTION
1. Please state your hypotheses in this section and limit the text to a few lines. Do not cut and paste
passages from your grant application
2. Provide a concise description including all steps, in chronological order, the experimental course of an
animal from its entry into the experiment to the endpoint of the study. Do not include specific
information about timepoints, doses, routes, sampling, SOPs etc. in the description, as this
information must be included in your table.

B. TABLE OF EXPERIMENTAL DESIGN AND ANIMAL PROCEDURES - You must provide a table or
tables that includes the following:
 Animal Group Composition - It is recommended that you describe each group and assign a number that
you can reference in your table (Example 1.1, 1.2, 2.1).
 Sampling, Procedures, Drugs, Compounds– You must include all procedures and sampling. Sampling
information must include the frequency, number of samples, volume, and type of sampling. All drugs or
compounds given must be listed on the table and include the dose, route and frequency.
Version 2012
Page 4 of 11


Time points – You must list the time points on the table and be sure to include whether you are using day,
week, month, or year.
Please provide a table title reference if using more than one table.
Insert table
C. STANDARD OPERATING PROCEDURES (SOPs)
Procedures may reference an approved TNPRC SOP/Policy in lieu of a complete description. The dropdown menus
below list the most common procedures conducted. Please choose all of the SOPs that will be used on your study.
The SOP/policy table of contents is available upon request to iacuc@tulane.edu.
If there is no approved SOP, then a complete description must be included in the Concise Description (B.).
.
.
.
.
.
.
.
.
.
.
List any SOPs (# and title) that will be used but are not on the menu above:
* I understand that the no more than 12.0 ml of blood per kilogram of body weight in a four-week period can be
collected.
D. PROPOSED TREATMENTS
 Pain and Distress: Describe the use of analgesics, anesthetics, and tranquilizing drugs to minimize
discomfort, distress, pain and injury. The list below contains some common drugs and doses for nonhuman
primate use and must be checked if they will be administered in this protocol.
DRUG
FREQUENCY
DOSE
Preanesthetic Drugs
0.01mg/kg
0.2mg/kg
Glycopyrrolate
Acepromazine
Other:
Anesthetic Drugs
1.5-2.5% to effect
10mg/kg
8mg/kg
Isoflurane gas
Ketamine hydrochloride
Tiletimine/zolazepam (Telazol)
Other:
Analgesic Drugs
0.013mg/kg
0.01mg/kg
Butorphanol (Torbutrol)
Buprenorphine
Meloxicam (Metacam)
Other

ROUTE
FREQUENCY
im/iv
im
Prior to anesthesia
Prior to anesthesia
inhalation
im
im
Continuous
prn
prn
im
im
Oral
tid
bid
Once a day
List all drugs, agents, compounds, and substances that are introduced to the animals throughout the study
period as described in the complete description.
SELECT TYPE
.
.
Version 2012
NAME
DOSE
Page 5 of 11
ROUTE
.
.
.
IN VIVO RADIONUCLIDE(s)
INSECT VECTORS
VOLUME
NUMBER
MODE
E. VETERINARY CARE
Routine care as specified in the standard operating procedures of the Division of Veterinary Medicine (985-8716266)
Special care. Provide a plan of action including phone numbers of essential personnel.

F. ADVERSE EFFECTS
Please list any adverse effects or reactions that have been documented or could be expected from the use of the test
article (drug, inoculum. antibody, other material or devices) animal phenotype or procedure during the study. If
none are expected, please state that and provide information that supports the statement.

Please list what treatment plan(s) will be employed in response to such adverse effects, should they be noted during
the course of this study.

G. ENDPOINTS
The TNPRC endpoint policy is acceptable for this study.
There is NO ANIMAL ENDPOINT to this study other than the approved study period. At the end of the
study the animals may be returned to the general colony and euthanasia is not required. However, if an animal’s
physical condition deteriorates the TNPRC endpoint policy is acceptable for this study.
The endpoints for this study are time based and noted on the Experimental Design table in Section VII.B.
However, if an animal’s physical condition deteriorates the TNPRC endpoint policy is acceptable for this
study.
I choose not to use the TNPRC endpoints - Please list the criteria to use to determine when euthanasia will
be performed. You must provide justification supported by references if you choose not to use the TNPRC
endpoints.

H. EUTHANASIA METHOD
The standard method of euthanasia for nonhuman primates at the TNPRC follows the IACUC approved TNPRC
SOP 3.23 Euthanasia Procedures in Nonhuman Primates. This method is consistent with the recommendation of the
American Veterinary Medical Association Guidelines on Euthanasia. http://www.avma.org/issues/
The TNPRC method of euthanasia is acceptable for this study.

If you propose to use a different method of euthanasia, please provide a description and if a chemical agent is
used, specify the dosage and route of administration in your description.

Version 2012
Page 6 of 11
YES, the method described above is consistent with the recommendation of the AVMA Guidelines on
Euthanasia.
NO, it is not consistent. Please provide justification (supported with references) for not following the
recommendation:
SECTION VIII. ANIMAL USE JUSTIFICATION
A. RATIONALE FOR ANIMAL USE. It must include the reasons why non-animal models cannot be used.

B. APPROPRIATENESS OF THE SPECIES SELECTED (Please address if preliminary studies have been
conducted using other species or lower life forms.)

C. ANIMAL NUMBER JUSTIFICATION
Please identify the approaches listed below used to justify the number of proposed animals for this study and
provide an explanation. More than one justification may be necessary for renewal protocols.
Citation of previous research - Please provide sufficient information, accompanied by your citation to
indicate that the previous research is similar enough in concept and methodology to make it reasonable to use
similar sample sizes in the proposed research project.
Explanation
Statistical analysis- if numbers are chosen with the intent of obtaining statistically significant differences, the
most objective tool is usually a power analysis to determine sample size. When groups are compared, the
goal of conducting a power analysis is to determine the appropriate number of animals per group to ensure
detection of a significant difference. Please use the attached link for an example of the information needed to
review a power analysis
Explanation
Pilot study- the following information must be included:
 Main outcome measure being evaluated (e.g. reduction in tumor size)
 The definition of success (e.g., a 50% reduction in tumor size in 3 animals) that would indicate
that the study should be followed up by a full study.
Explanation
Teaching or Training
Explanation

Is your study a USDA Category D or E? (Noted in Section III)
No – Skip the next section and proceed to Section X.
Yes - Please complete Section IX
Version 2012
Page 7 of 11
SECTION IX. ALTERNATIVES TO PAINFUL AND DISTRESSFUL PROCEDURES
As required by Policy 12 of the Animal Welfare Act, “the IACUC is required to assure that the principal investigator
has considered alternatives to procedures that may cause more than momentary or slight pain or distress” and “that
the PI has provided a written narrative description of the methods and sources, such as the Animal Welfare
Information Center, Biological Abstracts, Index Medicus, PubMed, and the Current Research Information Service.”
Alternatives are defined as new methods that refine existing usage by minimizing animals’ distress such as the use
of analgesics, reduce animal usage such as the use of certain experimental designs, or replace whole animal tests
with other procedures such as the use of in vitro analyses.
Database
Used
Date of
search
Period
covered by
search
Keywords used
Alternatives must be one of the
key words
Number
of
relevant
references
Were
alternatives
found
If alternatives were found, justify why they are not being used.

Additional relevant sources may include scientific meetings, scientific discussion, consultation with veterinary
faculty and federal law or other legal guidelines. Please list below.

SECTION X.
ENVIRONMENTAL ENHANCEMENT OF NONHUMAN PRIMATES
The United States Animal Welfare Act requires research facilities to provide environmental enhancement to
promote the psychological well-being of nonhuman primates. To assist in meeting these requirements, please
consider the needs of all nonhuman primates involved in the project, and indicate housing categories and enrichment
categories that will be appropriate for the duration of the study. If different components of the study have different
housing and/or enrichment needs, please indicate all that apply. Contact the Environmental Enrichment Coordinator
in the Division of Veterinary Medicine (985-871-6578) if you need additional information concerning the categories
or enrichment options. Categories selected by the investigator may be changed, with investigator approval, to
accommodate health, behavior, or management needs of the animals.
A. HOUSING CATEGORIES: (Select all that apply) For protocols involving more than one housing category or
species, indicate the phase of the study, treatment groups, or species to which the categories apply. Please
specify if there are constraints within a socialization category, i.e. if only those individuals in the same arm of
the study can be housed together. Explanations must be explicit. Statements such as "the research or the
science requires separate housing", without substantive justification will not be accepted.
GROUP HOUSING - Three or more monkeys housed together in the same enclosure. This housing
category is considered optimal for all age classes but especially encouraged for infants and young juveniles. No
justification of this category is required. Comments:
PAIR HOUSING - Two monkeys housed together in a specific enclosure or cage. This category is
particularly encouraged for infants and young juveniles when group housing is not feasible. No justification of
this category is required.
If there are restrictions to the composition of social groups (e.g. treatment groups and/or age/sex), please
specify:
Version 2012
Page 8 of 11
PROTECTED CONTACT HOUSING - Two monkeys housed in adjacent cages separated by a partition
that permits social contact. This setting is encouraged for subjects who would otherwise by singly housed due
to differences in diets between individuals, or due to frequent removal from primary housing for procedures.
This setting also reduces the risks of injury to surgical sites and experimental appliances. The specific type of
pairing may be selected. This housing option MUST be scientifically justified.
If there are restrictions to the composition of social groups (e.g. treatment groups and/or age/sex), please
specify:
Scientific justification for protected contact housing is as follows:
SINGLE HOUSING - A monkey housed alone, with visual, auditory, and olfactory contact with others of
the same or compatible species. Investigators requesting this type of housing MUST provide justification. This
housing option is particularly discouraged for infants and young juveniles due to its persistent negative effects
on development.
Scientific justification for single housing is as follows: 
ISOLATION HOUSING - A monkey housed alone without visual, auditory, and olfactory contact with
others of the same or compatible species. Monkeys housed in this manner must receive supplementary human
attention and inanimate environmental enrichment. Investigators requesting this type of housing MUST
provide justification. This housing option is particularly discouraged for infants and young juveniles due to its
persistent negative effects on development.
Scientific justification for isolation housing is as follows: 
B. ENRICHMENT CATEGORIES (Select all that apply).
For protocols involving more than one enrichment category, indicate the phase of the study, treatment group, or
species to which the category applies.
STANDARD ENRICHMENT - This type of enrichment is appropriate for the vast majority of research
projects. This type includes:
 Manipulable items in cage
 Perches or swings
 Various food supplements (fruit, vegetables, primate treats)
 Foraging or task-oriented feeding methods
 Human interaction with caretakers and research staff
The implementation is tailored to the species as dictated by the Animal Welfare Act and outlined in the
Tulane National Primate Research Center Policy on Environmental Enrichment. Animals showing signs of
being in psychological distress through behavior or appearance must receive special attention, which may
include additional enrichment devices, alterations to room configurations, and/or clinical intervention.
RESTRICTED ENRICHMENT - If any of the types of enrichment listed above are not compatible with the
proposed research, describe each exception and provide justification. Note that study subjects CANNOT be
exempted from all enrichment categories at any one time.
Scientific justification for restricted enrichment is as follows:
SECTION XI. PERSONNEL
Provide a listing of all personnel who will have direct contact with animals involved with the proposed
experimentation. Do not list veterinary medicine staff involved with the daily husbandry. You must list each
Version 2012
Page 9 of 11
person’s role on the project. All individuals must be appropriately qualified and trained in the proposed animal care
and use.
NAME/ TITLE
Only list people who
will have direct
contact with animals
SPECIFIC ROLE ON PROJECT -i.e.
surgery, tissue collection, euthanasia,
consult
TRAINING - List training for role or indicate
that additional training is needed.
Outside Persons who will conduct procedures Persons who will conduct any procedure on-site must have
completed the training and occupational health programs. All persons involved must complete the required training
prior to the start of the project.
DCM Downtown – 504-988-5211
TNPRC - Please contact the Occupational Nurse at 985-871-6596 to complete the necessary forms.
NAME/
TITLE
AFFLIATION
SPECIFIC ROLE ON PROJECT
-i.e. surgery, tissue collection,
euthanasia,
TRAINING - List training for role or
indicate that additional training is needed.
RISK ASSESSMENT AND HISTORY FORM (RAHF): All faculty, staff, and students who handle animals as a
part of this protocol must participate in the Animal Handlers Health Surveillance Program to include the completion
of the RAHF and the application of medical follow up as needed. For information or copies of these forms, please
contact:
Office of Environmental Health and Safety via email oehsrahf@tulane.edu or by telephone, 988-5486 (press 1)
TNPRC staff only - contact the Occupational Nurse at 985-871-6596
Access the form at: http://tulane.edu/oehs/
Version 2012
Page 10 of 11
SECTION XII. PRINCIPAL INVESTIGATOR CERTIFICATIONS
1.
2.
3.
4.
5.
6.
7.
8.
9.
I certify that the animal care and use described in this protocol is exactly as described in the funding
application (if applicable) for this protocol.
I certify that I have determined that the research proposed herein is not unnecessarily duplicative of
previously reported research.
I certify that all individuals working on this protocol are participating in the program administered by the
Tulane University Office of Environmental Health and Safety (OEHS).
I certify that the individuals listed under Personnel, if noted to do animal work, are authorized to conduct
procedures involving animals covered by this protocol, have received training in: the biology, handling, and
care of this species; aseptic surgical methods and techniques (if necessary); the concept, availability, and use
of research or testing methods that limit the use of animals or minimize distress; the proper use of anesthetics,
analgesic, and tranquilizers (if necessary); and procedures for reporting animal welfare concerns.
I understand that all personnel who will work on-site at TNPRC and will have contact with nonhuman
primates and/or their tissues and body fluids are required to complete the TNPRC Occupational Health and
Safety Program prior to the start of this project. This program includes a medical surveillance component
(e.g., semi-annual TB testing) and a training curriculum. I have been provided with written materials about
biohazard issues (macaque B virus, etc.) for dissemination to all personnel whose involvement will remain
off-site, but will receive samples of tissue or body fluid.
For all USDA Classification D and E protocols, I certify that I have reviewed the pertinent scientific literature
and have found no valid alternative to any procedures described herein which may cause more than
momentary pain or distress, whether it is relieved or not.
I certify that I will file the appropriate amendments and obtain approval from the IACUC before
implementing any changes in this study.
I certify that I will notify the IACUC regarding any unexpected study results that impact the welfare of the
animals. Any unanticipated pain or distress, morbidity or mortality will be reported to the attending
veterinarian and the IACUC.
I certify that I will comply with all pertinent institutional, State and Federal rules and policies.
I have read the assurances and I understand that failure to comply with these assurances may result in suspension or
termination of all animal activities and the filing of a report of non-compliance with the Institutional Official and the
appropriate governing agencies.
Principal Investigator
Version 2012
Date
Page 11 of 11